C12N 2770/20064
By serial passage
Official title: by serial passage
C12N2770/20064 (By serial passage) appears on 15 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 15
- Published applications
- 16
- Assignees
- 11
- Inventors
- 47
- Latest grant
- 2 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 1 | 1 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 2 |
| 2017 | 2 | 1 |
| 2018 | 1 | 2 |
| 2019 | 2 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Attenuated IBV with extended cell culture and tissue tropism2 Sep 2025US 12,403,191 B2Boehringer Ingelheim Vetmedica GmbH
- Live attenuated Arkansas serotype infectious bronchitis virus vaccine13 Sep 2022US 11,441,127 B2University of Georgia Research Foundation, Inc.
- Attenuated bovine coronavirus and related vaccines8 Oct 2019US 10,434,168 B2Intervet Inc.
- Live attenuated Arkansas serotype infectious bronchitis virus vaccine25 Jun 2019US 10,329,538 B2University of Georgia Research Foundation, Inc.
- Adaptation of attenuated infectious bronchitis virus (IBV) to embryonic kidney cells and vaccine thereby produced9 Oct 2018US 10,092,639 B2Auburn University
- Immortalized cells for production of bioproducts, methods of producing bioproducts with an immortalized cell, and methods of making immortalized cells for production of bioproducts28 Aug 2025US 2025/0270509 A1John Paul II Medical Research Institute
- Attenuated ibv with extended cell culture and tissue tropism30 Jun 2022US 2022/0202931 A1Boehringer Ingelheim Vetmedica GmbH
- Live attenuated arkansas serotype infectious bronchitis virus vaccine22 Apr 2021US 2021/0115410 A1University of Georgia Research Foundation, Inc.
- Live attenuated arkansas serotype infectious bronchitis virus vaccine29 Aug 2019US 2019/0264180 A1University of Georgia Research Foundation, Inc.
- Live attenuated arkansas serotype infectious bronchitis virus vaccine2 Aug 2018US 2018/0216082 A1University of Georgia Research Foundation, Inc.
Most cited
By later US patents
- Method of preparing an attenuated transmissible gastroenteritis (TGE) virus strain for use in live vaccines19US 4,159,319 A1979
- Feline infectious peritonitis virus vaccines12US 4,303,644 ANorden Laboratories, Inc. · 1981
- Method for propagating feline infectious peritonitis virus6US 4,293,653 A1981
- Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines6US 7,041,300 B1Cyanamid Iberica, S.A. · 2006
- Infectious bronchitis virus vaccine5US 7,291,342 B2Intervet International B.V. · 2007